Interview with Miomir Nikolic, Managing Director, Zdravlje Actavis
Throughout its history, Zdravlje Actavis has grown into one of the 3 companies that really define Serbian pharma. What have been the main factors that got Actavis into this leading…
Address: Djordja Stanojevica 12, 11 070 Novi Beograd, Srbija,
Tel: +381 11 20 99 300
Web: http://www.actavis.rs/sr/default.htm
A leading manufacturer of drugs for gastroenterology and cardiology for more than 50 years, Zdravlje has been part of Actavis Group since 2002 and continues to be one of the largest generic pharmaceutical companies in Serbia. Based in Leskovac, this EU GMP certified company is proud of its highly trained and committed personnel. With a portfolio of mainly solid oral dosages strenghtened with the choice of modern generic products transferred from Actavis’ broad portfolio, Zdravlje Actavis company maintains a strong position in its home market, breaking new grounds in the EU markets. Actavis d.o.o. (Sales & Marketing Office for Serbia and Montenegro region): a branch office for Sales and Marketing was established in Belgrade at the beginning of 2005. It continues to consolidate Actavis’ work in the region, spearheading a strategic expansion of product sales and the marketing of Zdravlje Actavis, along with the introduction of Actavis product portfolio on the markets in Serbia and Montenegro.
drugs
Throughout its history, Zdravlje Actavis has grown into one of the 3 companies that really define Serbian pharma. What have been the main factors that got Actavis into this leading…
Milica Glisic, with over 15 years of experience in the pharma business and ten years at Wörwag Pharma, discusses the strong workforce in the Balkans, Wörwag Pharma’s mission in the…
Siniša D. Vučinić, the brains behind Aqualab Plus Systems, which holds laboratories across Serbia that offer a variety of sophisticated blood tests specifically targeted at the elderly, pregnant women and…
Ronald Seeliger, CEO of Hemofarm group, arrived in Serbia during turbulent times in CEE. Following a strict program of reinvestment, local expertise, and innovative strategies, Hemofarm surged forwards, developing into…
Sanja Ivanic, director general of the French-Serbian Chamber of Commerce, discusses the advantages of working in Serbia, the opportunities that the country offers, Serbia’s entrance into the EU, the Chamber’s…
Vera Nikolic-Dimic, executive director of the American Chamber of Commerce (AmCham) in Serbia, pinpoints the key facets of the Serbian economy that have captivated the interests of American businesses, the…
Bojan Trkulja, managing director of INOVIA, Serbia’s innovative drug manufacturers association, underlines the importance of cooperation not only between his members but also between all the key stakeholders of the…
Rather than Mr. Bugarin’s personal views, the following information contains general statements provided by the Serbian Chamber of Commerce Current trends in pharmaceutical industry The production of the medicines in…
Priorities and plans of the Ministry of Health If we entered an election year with a major reform plan, we would not succeed in putting such proposals into parliamentary procedure.…
Roche is one of the oldest multinational pharmaceutical companies here in Serbia. How do you think your history in the country gives you an advantage today as a company? We…
Pfizer is increasingly interested in emerging markets, with a focus very much on Latin America and Asia. Given this, why is Serbia exciting for Pfizer today? Serbia is interesting for…
Serbia has had an undoubtedly troubled history since the breakup of Yugoslavia in the early 1990s. A costly war and ensuing UN sanctions have left the country’s economy a few…
As the 7th largest pharma MNC worldwide, AstraZeneca is a company that needs no introduction. However, our readers would love to hear more about your operations here in Serbia… Therefore,…
See our Cookie Privacy Policy Here